Clinical Trial: A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

U.S., April 29 -- ClinicalTrials.gov registry received information related to the study (NCT07553429) titled 'A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated' on April 22.

Brief Summary: This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses of a medicine called BI 3812465 are tolerated by people with this condition. This is the first time BI 3812465 is given to humans.

This study has 2 parts. In Part 1, a small number of participants receive low, medium, or high doses of BI 3812465. The first participants to start the study get low doses of BI 3812465. Participants who start l...